XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net loss $ (4,609) $ (35,078)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 7,025 7,230
Interest paid in kind 320 35
Stock-based compensation 2,544 12,059
Amortization of debt discount 2,652 986
Change in fair value of bifurcated embedded derivatives (732) (110)
Change in fair value of contingent consideration liability (2,220) (173)
Settlement of accrued expenses (7,649)
Impairment of fixed assets 146
Impairment of intangibles 1,356
Forgiveness of PPP Loans (2,511)
Loss on extinguishment of debt 4,321
Debt conversion expense 756
Deferred income taxes (41)
Changes in operating assets and liabilities:    
Accounts receivable (198) (7,297)
Prepaid expenses and other current assets (1,544) 921
Inventories 2 (328)
Other assets 221 255
Deferred revenue (168) 387
Accounts payable and accrued liabilities (1,770) 8,536
Other liabilities (174)
Net cash used in operating activities (4,624) (10,226)
Cash Flows from Investing Activities:    
Acquisition of Gramophone (150)
Purchases of property and equipment (2,036) (2,888)
Purchases of intangible assets (13) (84)
Net cash used in investing activities (2,049) (3,122)
Cash Flows from Financing Activities:    
Repayment of note payable (426) (351)
Proceeds from PodcastOne bridge loan 4,376
Payment of notes payable – related party (300)
Payments on capital lease liability (252)
Purchase of treasury stock (1,938)
Proceeds from exercise of employee stock options 872
Proceeds from drawdown on senior secured revolving line of credit 6,965
Proceeds from notes payable – related party 300
Net cash provided by financing activities 2,012 7,234
Net change in cash, cash equivalents and restricted cash (4,661) (6,114)
Cash, cash equivalents and restricted cash, beginning of period 13,154 18,770
Cash, cash equivalents and restricted cash, end of period 8,493 12,656
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 8
Cash paid for interest 1,264 1,081
Supplemental disclosure of non-cash investing and financing activities:    
Fair value of options issued to employees, capitalized as internally developed software 26 148
Fair value of 1,397,918 shares of common stock issuable in connection with the settlement of accrued expenses and prepayment for services 945
Fair value of 1,000,000 shares of common stock issuable in connection with the modification of debt instruments 1,142
Fair value of 414,137 shares of common stock issuable in connection with the settlement of earnout 493
Fair value of 60,000 shares of common stock issued in connection with Secured Convertible Notes 320
Fair value of 33,654 shares of common stock issued in connection with Unsecured Convertible Notes 122
Fair value of 1,155,143 shares of common stock issued upon conversion of Unsecured Convertible Notes 3,045
Forgiveness of PPP loan 2,511
Fair value of warrant and derivative liability issued with debt instruments 3,107
Fair value of shares issued in connection with CPS acquisition 2,127
Fair value of 79,365 shares of common stock issued in connection with the Gramophone acquisition 89
Fair value of unsecured convertible note premium $ 4,199